The treatment of diabetic retinopathy: a view for the internist.

Ann Intern Med

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8858.

Published: August 1992

AI Article Synopsis

  • This text reviews current treatments for diabetic retinopathy, focusing on both surgical and medical therapies, specifically for a non-specialist audience.
  • The data examined includes studies from 1981 to 1991, with emphasis on large randomized trials to ensure reliable conclusions about treatment effectiveness.
  • Surgical options like panretinal photocoagulation and vitrectomy show benefits in severe cases, while intensive insulin therapy and aldose-reductase inhibitors lack consistent efficacy in improving patient outcomes.

Article Abstract

Purpose: To review the status of surgical and medical therapy for diabetic retinopathy from the perspective of the non-ophthalmologist.

Data Sources: Relevant English-language articles published from January 1981 to July 1991 were identified through MEDLINE. Other relevant articles were obtained from the authors' personal database.

Study Selection: For the review of surgical treatment, large randomized, controlled trials were selected. For the review of medical treatment, randomized studies comparing intensive insulin treatment with conventional insulin therapy were selected, as were double-blind, randomized, controlled trials of aldose-reductase inhibitor therapy and antiplatelet therapy in patients with diabetic retinopathy.

Data Extraction: Emphasis is on findings from large, multicenter, randomized, controlled studies.

Data Synthesis: Surgery is effective in three clinical situations: Panretinal (scatter) photocoagulation is effective treatment for proliferative retinopathy that is likely to progress to severe visual loss, with such therapy resulting in a 50% to 60% decrease in the main outcome (visual acuity of 5/200 or less; focal photocoagulation decreases the incidence of deterioration of visual acuity by 60% in patients with clinically significant macular edema, but no benefit of photocoagulation has been shown in patients with mild-to-moderate background diabetic retinopathy; and vitrectomy is effective in improving visual acuity only in patients with severe, complicated proliferative retinopathy. Intensive insulin therapy has not been consistently effective in short-term studies with small numbers of subjects. Results of the Diabetes Control and Complications Trial should show whether intensive insulin therapy affects the course of diabetic complications. Aldose-reductase inhibitors have not shown efficacy in changing the course of diabetic retinopathy. Results of trials using antiplatelet agents are controversial.

Conclusions: Current therapy of diabetic retinopathy is based on detection and surgical treatment of advanced lesions. Medical interventions that effectively halt the progression or prevent the development of diabetic retinopathy are needed.

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-117-3-226DOI Listing

Publication Analysis

Top Keywords

diabetic retinopathy
24
randomized controlled
12
intensive insulin
12
insulin therapy
12
visual acuity
12
retinopathy
8
therapy
8
therapy diabetic
8
surgical treatment
8
controlled trials
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!